Arrhythmias & electrophysiology

Pulsed field ablation for atrial fibrillation in patients with heart failure: insight from the ATHENA registrys

EuropacePublished Registry-based cohort study

Authors' conclusion

PFA with the pentaspline catheter appears to be an effective treatment for AF in patients with HF. Freedom from AF and atrial arrhythmias post-PFA was highest in patients with paroxysmal AF and no history of HF, with no significant differences observed in persistent AF patients.

Study context

Population
Consecutive patients undergoing first-time pentaspline pulsed-field ablation (PFA) for atrial fibrillation (AF) (68.5% paroxysmal, 31.5% persistent), ATHENA registry176 (14.4%) with heart failure (HF)
Participants
1,224 patients
Exposure
HF vs no HF in patients undergoing pentaspline PFA for AF
  • HF with preserved ejection fraction (HFpEF)n = 40
  • HFmrEF/rEFn = 136
Outcome
Freedom from documented atrial arrhythmias >30 s after a 2-month blanking period
Follow-up
1-year follow-up
Methodological detailsconsecutive patients, stratified by HF subtype, AAD use left to physician discretion
  • Consecutive patients
  • Stratified by HF subtype
  • AAD use left to physician discretion

Main finding

As reported in the abstract

Freedom from any atrial arrhythmias (Kaplan-Meier)

HR for atrial arrhythmia recurrence

1.5

95% CI 1.1–2.1

P = 0.0133

By group

HFvs No HF
HR for atrial arrhythmia recurrence 1.5 (95% CI 1.1–2.1); P = 0.0133
Overall freedom from any atrial arrhythmias
79.9%

Observational data: associations, not effects.

Further findings

OutcomeNo HFHR for atrial arrhythmia recurrence (CI)P value
Freedom from atrial arrhythmias, paroxysmal AF (subgroup)HFvs No HF82.2%2.0 (1.3–3.1)P = 0.0028
Freedom from atrial arrhythmias, persistent AF (subgroup)HFvs No HFNo differences77.9%1.1 (0.7–1.7)P = 0.7065
  • Freedom from atrial arrhythmias, paroxysmal AF (subgroup): HF 68.6%
  • Freedom from atrial arrhythmias, persistent AF (subgroup): HF 76.4%

Original publication

Pulsed field ablation for atrial fibrillation in patients with heart failure: insight from the ATHENA registrys. Europace. Published 17 March 2026. doi:10.1093/europace/euag049

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.